FT  11 MAY 94 / World News in Brief: SmithKline Beecham
The Anglo-US drugs company is to launch an unbranded version of its former
best-selling ulcer drug Tagamet in the US, in an attempt to stave off
competition from cut-price generic products after the expiry of Tagamet's US
patent on May 17. Page 27; Industry seeks prescription for growth, Page 32
